Increased proportion of CD226 + CD14 + monocytes correlates with clinical features and laboratory parameters in patients with primary Sjögren's syndrome.

Ping ZhaoWei ChengCuiping LiuCheng PengYu ShenYanhong YangChao SunXin ChangJian Wu

Published in: International journal of rheumatic diseases (2023)

Our study suggested that an increased CD226 proportion on CD14 + monocytes was associated with the clinical manifestations, disease activity, and prognosis of pSS patients. CD226+ CD14 + monocytes may present a potential target and a biomarker for the prognosis and therapy of pSS patients.

Keyphrases

disease activity
end stage renal disease
ejection fraction
newly diagnosed
rheumatoid arthritis
dendritic cells
peripheral blood
patient reported outcomes
immune response
juvenile idiopathic arthritis
case report
mesenchymal stem cells
climate change
patient reported
cell therapy